2024-05-19
2024-02-08
Summary | |
---|---|
Cancer Type | Lung Cancer |
Grade | NA |
Stage | NA |
Ethnicity | Western |
Gender | F |
Age | 60 |
Pathology Diagnosis | Poorly differentiated malignant tumour T2a N0 M0 V0 R0. UPDATE- in view of the absence of an alternative primary site we regard this tumour as a poorly differentiated non-small cell carcinoma of the lung. |
Biopsy Site | NA |
Treatment History | NA |
Pathology QC | Small round cell malignant tumor, and need to exclude malignant melanoma (P5, P7); IHC (P9): CK7(-),CD57(-),HMB45(-),CK5/6(-),P63(cytoplasmic staining 3+), TTF1(-), CK8/18(-), SYN (2+), EMA (2+). |
Special Features | NA |
Mouse Strain | Balb/c nu, MF-1 nu |
TMA | TMA-HP-LU-017 |
Viral Status in PDX | NA |
Available In | CB_CN, CB-UK |
RNA Seq | P4 |
Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy